218 related articles for article (PubMed ID: 32424620)
1. Cardiac and neuronal HCN channelopathies.
Rivolta I; Binda A; Masi A; DiFrancesco JC
Pflugers Arch; 2020 Jul; 472(7):931-951. PubMed ID: 32424620
[TBL] [Abstract][Full Text] [Related]
2. Hyperpolarization-activated and cyclic nucleotide-gated channel proteins as emerging new targets in neuropathic pain.
He JT; Li XY; Zhao X; Liu X
Rev Neurosci; 2019 Jul; 30(6):639-649. PubMed ID: 30768426
[TBL] [Abstract][Full Text] [Related]
3. HCN-related channelopathies.
Baruscotti M; Bottelli G; Milanesi R; DiFrancesco JC; DiFrancesco D
Pflugers Arch; 2010 Jul; 460(2):405-15. PubMed ID: 20213494
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional HCN ion channels in neurological diseases.
DiFrancesco JC; DiFrancesco D
Front Cell Neurosci; 2015; 6():174. PubMed ID: 25805968
[TBL] [Abstract][Full Text] [Related]
5. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy.
Resta F; Micheli L; Laurino A; Spinelli V; Mello T; Sartiani L; Di Cesare Mannelli L; Cerbai E; Ghelardini C; Romanelli MN; Mannaioni G; Masi A
Neuropharmacology; 2018 Mar; 131():403-413. PubMed ID: 29339292
[TBL] [Abstract][Full Text] [Related]
6. HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature.
DiFrancesco JC; Castellotti B; Milanesi R; Ragona F; Freri E; Canafoglia L; Franceschetti S; Ferrarese C; Magri S; Taroni F; Costa C; Labate A; Gambardella A; Solazzi R; Binda A; Rivolta I; Di Gennaro G; Casciato S; D'Incerti L; Barbuti A; DiFrancesco D; Granata T; Gellera C
Epilepsy Res; 2019 Jul; 153():49-58. PubMed ID: 30986657
[TBL] [Abstract][Full Text] [Related]
7. Involvement of hyperpolarization-activated, cyclic nucleotide-gated cation channels in dorsal root ganglion in neuropathic pain.
Wan Y
Sheng Li Xue Bao; 2008 Oct; 60(5):579-80. PubMed ID: 18958363
[TBL] [Abstract][Full Text] [Related]
8. Hyperpolarization-activated cyclic-nucleotide-gated channels: pathophysiological, developmental, and pharmacological insights into their function in cellular excitability.
Spinelli V; Sartiani L; Mugelli A; Romanelli MN; Cerbai E
Can J Physiol Pharmacol; 2018 Oct; 96(10):977-984. PubMed ID: 29969572
[TBL] [Abstract][Full Text] [Related]
9. Hyperpolarization-activated cyclic-nucleotide-gated channels potentially modulate axonal excitability at different thresholds.
Weerasinghe D; Menon P; Vucic S
J Neurophysiol; 2017 Dec; 118(6):3044-3050. PubMed ID: 28904107
[TBL] [Abstract][Full Text] [Related]
10. Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels as Drug Targets for Neurological Disorders.
Santoro B; Shah MM
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():109-131. PubMed ID: 31914897
[TBL] [Abstract][Full Text] [Related]
11. HCN1 channels as targets for anesthetic and nonanesthetic propofol analogs in the amelioration of mechanical and thermal hyperalgesia in a mouse model of neuropathic pain.
Tibbs GR; Rowley TJ; Sanford RL; Herold KF; Proekt A; Hemmings HC; Andersen OS; Goldstein PA; Flood PD
J Pharmacol Exp Ther; 2013 Jun; 345(3):363-73. PubMed ID: 23549867
[TBL] [Abstract][Full Text] [Related]
12. HCN3 ion channels: roles in sensory neuronal excitability and pain.
Lainez S; Tsantoulas C; Biel M; McNaughton PA
J Physiol; 2019 Sep; 597(17):4661-4675. PubMed ID: 31290157
[TBL] [Abstract][Full Text] [Related]
13. Peripheral hyperpolarization-activated cyclic nucleotide-gated channels contribute to inflammation-induced hypersensitivity of the rat temporomandibular joint.
Hatch RJ; Jennings EA; Ivanusic JJ
Eur J Pain; 2013 Aug; 17(7):972-82. PubMed ID: 23255289
[TBL] [Abstract][Full Text] [Related]
14. Pacemaking Activity in the Peripheral Nervous System: Physiology and Roles of Hyperpolarization Activated and Cyclic Nucleotide-Gated Channels in Neuropathic Pain.
Liu F; Wuni GY; Bahuva R; Shafiq MA; Gattas BS; Ibetoh CN; Stratulat E; Gordon DK
Cureus; 2020 Oct; 12(10):e11111. PubMed ID: 33240707
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of HCN2 channel protein in L4 dorsal root ganglion neurons following axotomy of L5- and inflammation of L4-spinal nerves in rats.
Smith T; Al Otaibi M; Sathish J; Djouhri L
Neuroscience; 2015 Jun; 295():90-102. PubMed ID: 25813712
[TBL] [Abstract][Full Text] [Related]
16. HCN channels and absence seizures.
Crunelli V; David F; Morais TP; Lorincz ML
Neurobiol Dis; 2023 Jun; 181():106107. PubMed ID: 37001612
[TBL] [Abstract][Full Text] [Related]
17. Shank3-deficient thalamocortical neurons show HCN channelopathy and alterations in intrinsic electrical properties.
Zhu M; Idikuda VK; Wang J; Wei F; Kumar V; Shah N; Waite CB; Liu Q; Zhou L
J Physiol; 2018 Apr; 596(7):1259-1276. PubMed ID: 29327340
[TBL] [Abstract][Full Text] [Related]
18. Molecular and functional analysis of hyperpolarisation-activated nucleotide-gated (HCN) channels in the enteric nervous system.
Xiao J; Nguyen TV; Ngui K; Strijbos PJ; Selmer IS; Neylon CB; Furness JB
Neuroscience; 2004; 129(3):603-14. PubMed ID: 15541882
[TBL] [Abstract][Full Text] [Related]
19. An evolutionarily conserved pacemaker role for HCN ion channels in smooth muscle.
Yang L; Arbona RJR; Smith CS; Banks KM; Thomas VK; Palmer L; Evans T; Hurtado R
J Physiol; 2023 Apr; 601(7):1225-1246. PubMed ID: 36930567
[TBL] [Abstract][Full Text] [Related]
20. HCN Channels: New Therapeutic Targets for Pain Treatment.
Ramírez D; Zúñiga R; Concha G; Zúñiga L
Molecules; 2018 Aug; 23(9):. PubMed ID: 30134541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
